Powerful Medical
11. November 2023

PMcardio Is the World’s First Certified AI-Powered Medical Device to Detect Acute Coronary Occlusion From the ECG

AI-Powered Medical Device to Detect Acute Coronary Occlusion From the ECG


PMcardio announces the launch of the Queen of Hearts, a certified medical device AI algorithm that represents a landmark moment in detecting and consequently timely treatment of acute obstructive heart attacks, termed Acute Occlusion Myocardial Infarction (OMI). With 50 million patients worldwide presenting to emergency departments with chest pain annually, the current standard of care often misidentifies and delays treatment in 50% of OMI patients who urgently need intervention. On the other hand, most hospitals also suffer from 20-40% false positive cath lab activation rates due to false positive ST elevation criteria.

The OMI Paradigm has been pioneered by Prof. Dr. Stephen W. Smith and Dr. H. Pendell Meyers. It addresses the limitations of the traditional dichotomous STEMI/NSTEMI model, which neglects dynamic ECG changes throughout the evolution of occlusive myocardial infarction requiring emergent reperfusion. The OMI identification at the time of the first point of contact is challenging and may require sequential ECG evaluations, leading to unnecessary and potentially harmful delays in myocardial revascularization.

“When treating patients with symptoms potentially indicating Acute Coronary Syndrome (ACS), immediate and accurate diagnosis is crucial for timely intervention. The Queen of Hearts leverages decades of our ECG morphology research to accurately distinguish acute occlusions from patterns which mimic them, going beyond mere ST-elevation analysis”, states Dr. Smith, faculty physician at the Emergency Medicine Residency, Hennepin County Medical Center and Professor of Emergency Medicine at the University of Minnesota, and founder of Dr. Smith’s ECG Blog.

The Queen of Hearts excels in detecting subtle and complex patterns on ECGs, according to a recent international study accepted in the European Heart Journal – DH. Enrolling over 2,000 acute coronary patients across three sites (EU and US), the model was found to be twice as sensitive compared to the current standard of care and detected acute coronary obstructed heart attacks (STEMI equivalents) three hours earlier.

“The OMI AI Model demonstrates unparalleled promise in treating acute coronary patients with acute occlusive coronary lesions. The rapid and accurate identification of such patients often presenting without typical ST-elevation at first medical contact – either in the ambulance or emergency triage. From a single ECG, the tool immediately provides the pivotal clinical solution to prevent increased risk for heart failure or mortality due to delayed revascularization of large myocardial infarctions”, states Dr. Jozef Bartunek, Co-Director of Cardiovascular Center Aalst, OLV Hospital in Belgium.

Serving as a critical link between emergency physicians and cardiologists, the OMI AI Model ensures that both specialties align in the swift and accurate diagnosis of acute coronary occlusions. In emergency care, paramedics can use the Queen of Hearts to diagnose patients with OMI at the scene or in the ambulance and immediately communicate the need for urgent catheterization lab activation well before arrival at the hospital. This ensures that patients receive immediate and appropriate care and are quickly prioritized upon arrival at the emergency department.

“The impact of our technology is not limited to the immediate treatment of heart attacks; it extends into the future well-being of patients. Our AI models in development focus on ECG-based screening for heart failure as early as asymptomatic patients presenting for a routine check-up to their GP and early recognition of sudden cardiac death, such as Brugada and Hypertrophic Cardiomyopathy, ensuring patients have the best chance for a healthier, longer life”, concludes Dr. Robert Herman, Research, Digital, and Innovation Committee Member at the European Society of Cardiology and Chief Medical Officer at Powerful Medical, the deep-tech company behind PMcardio.

Try PMcardio for free

About the Queen of Hearts:

PMcardio’s OMI AI Model, also known as the Queen of Hearts, enables physicians to detect Occlusion Myocardial Infarction (OMI) from any 12-lead ECG regardless of typical ST elevation. The current gold standard misidentifies half of patients in urgent need of treatment for Acute Coronary Occlusion. The Queen of Hearts was developed and clinically validated to improve the early diagnosis of acute obstructive heart attacks in order to improve patient referral and outcomes.

Get in touch with our Communications Team at communications@powerfulmedical.com.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Wellens syndrom ECG - Blog

Facing Wellens’ Syndrome: Are You Prepared to Prevent Acute Coronary Occlusions?

Wellens' Syndrome is a condition representing a reperfusion state post coronary artery occlusion, marked by distinctive ECG changes. This condition demands urgent recognition and intervention to prevent the progression to an extensive anterior wall myocardial infarction (MI).

Gearing Up for the US Market: PMcardio Showcases at ACC.24

We're thrilled to share our experience at the American College of Cardiology's 24th annual meeting (ACC.24) in Atlanta, where we showcased our AI-powered ECG interpretation platform

Join 25,000 healthcare professionals who are already taking advantage of AI